Innoprot offer Human and animal primary cells immortalized with SV40 antigen T and other immortalization techniques. All immortalized cell lines has been characterized for specific markers and other for functional assays.
Immortalized Human Aortic Endothelial Cells (IM-HAEC) provided by Innoprot have been developed by immortalizing primary human aortic endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HAEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HAEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HAEC culture.
Immortalized Human Astrocytes (IM-HA) provided by Innoprot have been developed by immortalizing primary human cortical astrocytes with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HA contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HA which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HA culture.
Immortalized Human Bladder Smooth Muscle Cells (IM-HBlSMC) provided by Innoprot have been developed by immortalizing primary human bladder smooth muscle cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of HBlSMC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of HBlSMC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro HBlSMC culture.
Immortalized Human Brain Microvascular Endothelial Cells (IM-HBMEC) provided by Innoprot have been developed by immortalizing primary human brain endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HBMEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HBMEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HBMEC culture.
Immortalized Human Bronchial Epithelial Cell Line (IM-HBEpiC) provided by Innoprot have been developed by immortalizing primary human bronchial epithelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HBEpiC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HBEpC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HBEpiC culture.
Immortalized Human Cardiac Fibroblasts (IM-HCF) provided by Innoprot have been developed by immortalizing primary human cardiac fibroblasts with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HCF contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HCF which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HCF culture.
Immortalized Human Colonic Fibroblasts (IM-HCoF) provided by Innoprot have been developed by immortalizing primary human healthy colonic fibroblasts with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Colonic Fibroblasts contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HCoF which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HCoF culture.
Immortalized Human Conjunctival Epithelial Cell Line (IM-HConEpiC) provided by Innoprot have been developed by immortalizing primary human cojunctival epithelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HConEpiC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HConEpC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HConEpiC culture.
Immortalized Human Corneal Endothelial Cells (IM-HCEC) provided by Innoprot have been developed by immortalizing primary human corneal endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HCEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HCEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HCEC culture.
Immortalized Human Corneal Epithelial Cell Line (IM-HCEpiC) provided by Innoprot have been developed by immortalizing primary human corneal epithelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HCEpiC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HCEpC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HCEpiC culture.
Immortalized Human Dermal Fibroblasts (IM-HDF) provided by Innoprot have been developed by immortalizing primary human healthy dermal fibroblasts with hTERT.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the hTERT‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Dermal Fibroblasts contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HDF which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HDF culture.
Immortalized Human Dermal Microvascular Endothelial Cells (IM-HDMEC) provided by Innoprot have been developed by immortalizing primary human dermal endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HDMEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HDMEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HDMEC culture.
Immortalized Human Gingival Fibroblasts (IM-HGF) provided by Innoprot have been developed by immortalizing primary human gingival fibroblasts with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HGF contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HGF which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HGF culture.
Immortalized Human Hepatic Sinusoidal Endothelial Cells (IM-HHSEC) provided by Innoprot have been developed by immortalizing primary human hepatic sinusoidal endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-IM-HHSEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-IM-HHSEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HHSEC culture.
Immortalized Human Hepatic Stellate Cells (IM-HHSteC) provided by Innoprot have been developed by immortalizing primary human healthy hepatic stellatat ceels wiyh SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Hepatic Stellate Cells contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HSteC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HSteC culture.
Immortalized Human Keratocytes (IM-HK) provided by Innoprot have been developed by immortalizing primary human keratocytes (a.k.a. corneal fibroblasts) with HPV16 E6/E7 gene.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the HPV16 E6/E7 gene‐tranduced cells go beyond 30 passages.
Each vial of Immortalized human keratocytes contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HK which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HK culture.
